Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 740 shares at $12.61 ($10K) on 2023-03-20, disclosed to the SEC on 2023-03-21.
Open-market sale of $10k TARS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.28 | 360 | $5K | 49.9% |
| 2 | $12.61 | 380 | $5K | 50.1% |
| Total | $12.94 avg | 740 | $10K | 100% |
| Filing → |
| TARS | SELL | 2026-03-19 | $772K | — | Filing → |
| TARS | SELL | 2026-03-05 | $641K | — | Filing → |
| TARS | SELL | 2025-03-20 | $726K | — | Filing → |